Company Filing History:
23 out of 2,078 
15 out of 363 
1 out of 1 Years Active: 2002-2017
Areas of Expertise:
Title: The Innovative Journey of J Guy Breitenbucher
Introduction: J Guy Breitenbucher, based in Escondido, California, is a prolific inventor with an impressive portfolio of 41 patents to his name. His work primarily focuses on developing novel compounds that serve as modulators for the TRPV1 protein, which plays a crucial role in pain and inflammatory responses.
Latest Patents: Among his latest innovations, two notable patents stand out. The first pertains to "Tetrahydro-pyrimidoazepines as modulators of TRPV1," where certain tetrahydro-pyrimidoazepine compounds are explored for their potential in pharmaceutical applications aimed at treating various conditions such as pain, itch, cough, asthma, and inflammatory bowel disease. The second patent focuses on "Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1." This invention describes compounds that can similarly be employed in therapeutic compositions for addressing pain, arthritis, and other disorders mediated by TRPV1 activity.
Career Highlights: Throughout his career, J Guy Breitenbucher has made significant contributions to the pharmaceutical industry. He has worked with prominent companies such as Janssen Pharmaceutica NV and Ortho-McNeil Pharmaceutical Corporation, where he played a vital role in advancing innovative therapeutic solutions.
Collaborations: Breitenbucher has collaborated with noteworthy professionals in his field, including Hui Cai and James Patrick Edwards. These partnerships have undoubtedly enriched his research and development efforts, fostering an environment of innovation and discovery.
Conclusion: With his extensive experience and a robust list of patents, J Guy Breitenbucher continues to be a key figure in pharmaceutical innovation. His work not only advances scientific knowledge but also has the potential to significantly improve patient care through the development of new therapeutic agents.